SYNLAB UK & Ireland
Peter Llewelyn began their work experience in 2006 as a QC Chemist at Clariant, where they later transitioned to a role as a Research Chemist. In 2007, they joined Norgine as a Pharmaceutical Development Analyst, leading a project for a medical device and handling technical documentation. From 2012 to 2022, Peter worked at Cardiff University as a Production Manager for PETIC, overseeing the production of radio-pharmaceuticals and ensuring pharmaceutical and radiation safety. Peter then became the Head of Operations at BioMonde UK in 2022. Currently, Peter is employed as the Head of Toxicology at SYNLAB UK & Ireland.
Peter Llewelyn pursued their education in the field of Chemistry, starting with a Bachelor of Science (BSc) degree from Swansea University from 1999 to 2002. Following this, they obtained a Master of Research (MRes) degree in Clean Chemical Technology from the University of York in 2002-2003. Lastly, they completed their educational journey with a Doctorate (PhD) in Heterogeneous Catalysis from Cardiff University / Prifysgol Caerdydd, spanning the years 2003 to 2006.
This person is not in any teams
This person is not in any offices
SYNLAB UK & Ireland
3 followers
At SYNLAB, we provide laboratory, diagnostic and advisory services to a diverse range of sectors, from healthcare, wellness and veterinary, to food, family law and transport. We carry out over 25 million tests every year and employ more than 1,300 people across the UK and Ireland. We pride ourselves on the positive difference we make to people, animals, the environment, workplaces and other consumers by providing reliable, effective and timely diagnostic information. Our extensive network of laboratories offers thousands of different types of tests. These include routine blood, toxicology, food, fuel, water and soil analysis through to cutting edge molecular and genetic testing. At SYNLAB, we are committed to advancing scientific and clinical practice through innovation, research and development. All our laboratories comply with industry standards and hold the accreditations relevant to their field of work. We are proud to work with the NHS through a number of hospital partnerships. These combine clinical excellence with the very best in innovation and transformation. SYNLAB’s involvement has enabled the NHS to realise a number of benefits, such as major improvements to patient services, better value for money and access to state-of-the-art laboratories and diagnostic services. SYNLAB UK & Ireland is part of SYNLAB Group, Europe’s leading medical diagnostic services provider.